Results 161 to 170 of about 76,921 (190)
Some of the next articles are maybe not open access.
All orthostatic hypotension is neurogenic
Clinical Autonomic Research, 2023openaire +2 more sources
Efficacy of Midodrine for Neurogenic Orthostatic Hypotension
JAMA: The Journal of the American Medical Association, 1997To the Editor. —Orthostatic hypotension due to autonomic failure is an incapacitating condition for which treatment, despite various drug interventions (eg, yohimbine, metoclopramide, β-blockers, somatostatin analog) is not yet resolved. Therefore, the encouraging results of the study of Dr Low and colleagues 1 are potentially of great importance ...
openaire +1 more source
Droxidopa approved for neurogenic orthostatic hypotension
American Journal of Health-System Pharmacy, 2014Droxidopa, a synthetic amino acid precursor of norepinephrine, has been approved as oral therapy for the treatment of neurogenic orthostatic hypotension, FDA and Chelsea Therapeutics announced on February 18.
openaire +1 more source
Neurogenic Orthostatic Hypotension
2014Eduardo E. Benarroch, Wolfgang Singer
openaire +1 more source
Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms
Journal of Neural Transmission, 2017Gregor Wenning +2 more
exaly
Fall-related healthcare use and costs in neurogenic orthostatic hypotension with Parkinson’s disease
Journal of Medical Economics, 2017Italo Biaggioni +2 more
exaly